Rare giant ovarian metastasis arising from a small primary lung adenocarcinoma: a case report
- PMID: 37780910
- PMCID: PMC10536256
- DOI: 10.3389/fsurg.2023.1278076
Rare giant ovarian metastasis arising from a small primary lung adenocarcinoma: a case report
Abstract
This intricate case report details an exceptionally rare incidence of ovarian metastasis originating from a primary lung adenocarcinoma (LUAD). The relative rarity of this metastatic pathway in medical literature indicates significant diagnostic challenges. This patient was initially found to have both the ovarian tumor and lung nodule and they were originally considered independent primary tumors, derived from radiological interpretations and biomarker profiling. Nevertheless, subsequent postoperative histopathological and immunohistochemical staining evaluations identified ovarian tumors as invasive adenocarcinoma metastasized from lung. The lung and ovary tumor both showed marked anaplastic lymphoma kinase gene (ALK) protein expression by immunohistochemistry. The molecular pathologic genetic testing for lung tumor also revealed ALK rearrangement positive. The complexity of this case underscores the essentiality of maintaining a high degree of diagnostic vigilance, particularly when confronting synchronous tumors. In addition, immunohistochemical staining plays an important role in diagnosing the ovarian neoplasm's metastatic nature and determining the primary site of metastatic adenocarcinoma. For lung cancer with ovary metastasis patients, the adopting an adaptable treatment approach responsive to evolving diagnostic evidence can improve the accuracy of diagnosis and avoid excessive treatment of patients.
Keywords: anaplastic lymphoma kinase gene (ALK); immunohistochemical staining; lung adenocarcinoma (LUAD); ovary metastasis; tumor markers.
© 2023 Wang, Jia, Wang, Zhang, Ding and Lu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Ovarian metastases from ALK-positive lung adenocarcinoma: a case report and review of the literature.Transl Cancer Res. 2022 Sep;11(9):3391-3399. doi: 10.21037/tcr-22-273. Transl Cancer Res. 2022. PMID: 36237252 Free PMC article.
-
ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma.Diagn Pathol. 2019 Aug 28;14(1):96. doi: 10.1186/s13000-019-0864-7. Diagn Pathol. 2019. PMID: 31455365 Free PMC article.
-
Ovarian metastasis from lung adenocarcinoma with ALK-positive rearrangement detected by next generation sequencing: A case report and literatures review.Cancer Biol Ther. 2017 May 4;18(5):279-284. doi: 10.1080/15384047.2017.1310344. Epub 2017 Mar 31. Cancer Biol Ther. 2017. PMID: 28362192 Free PMC article.
-
Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.BMC Cancer. 2019 Jan 11;19(1):52. doi: 10.1186/s12885-019-5277-1. BMC Cancer. 2019. PMID: 30634950 Free PMC article. Review.
-
Ovarian Metastases from ALK-rearranged Lung Adenocarcinoma: A Case Report and Literature Review.Intern Med. 2018 Nov 15;57(22):3271-3275. doi: 10.2169/internalmedicine.0538-17. Epub 2018 Jul 6. Intern Med. 2018. PMID: 29984766 Free PMC article. Review.
References
-
- Vašíková A. EML4-ALK Fusion gene in patients with lung carcinoma: biology, diagnostics and targeted therapy. Klin Onkol. (2012) 25:434–9. PMID: - PubMed
Publication types
LinkOut - more resources
Full Text Sources